Aisling Capital Revenue and Competitors
Estimated Revenue & Valuation
- Aisling Capital's estimated annual revenue is currently $15M per year.
- Aisling Capital's estimated revenue per employee is $750,000
- Aisling Capital's total funding is $307.9M.
Employee Data
- Aisling Capital has 20 Employees.
- Aisling Capital grew their employee count by 0% last year.
Aisling Capital's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and Senior Advisor | Reveal Email/Phone |
2 | Controller | Reveal Email/Phone |
3 | Director Investor Relations & Marketing | Reveal Email/Phone |
4 | Compliance Manager and Head HR | Reveal Email/Phone |
5 | Partner | Reveal Email/Phone |
6 | Managing Partner | Reveal Email/Phone |
7 | no title | Reveal Email/Phone |
8 | Exec Admin to Steve Elms and Eric Aguiar | Reveal Email/Phone |
9 | Administrative Professional | Reveal Email/Phone |
10 | Principal | Reveal Email/Phone |
Aisling Capital Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.5M | 18 | 0% | N/A | N/A |
#2 | N/A | 19 | -21% | N/A | N/A |
#3 | $7.5M | 57 | 21% | N/A | N/A |
#4 | $11830M | 36 | 44% | $1M | N/A |
#5 | $7.5M | 48 | 50% | $48.1M | N/A |
#6 | $15M | 123 | 17% | N/A | N/A |
#7 | N/A | 8 | -88% | N/A | N/A |
#8 | N/A | 24 | -11% | N/A | N/A |
#9 | N/A | 16 | 14% | N/A | N/A |
#10 | $7.5M | 53 | 20% | N/A | N/A |
What Is Aisling Capital?
Aisling Capital is a dedicated life sciences private equity firm with $1 billion under management. Headquartered in New York, Aisling Capital invests in both private and public companies utilizing a wide variety of investment structures. The Aisling Capital team's combination of clinical, operational and financial experience allows the firm to identify, execute and realize investments across the life sciences industry.
keywords:N/A$307.9M
Total Funding
20
Number of Employees
$15M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aisling Capital News
... participated in Novo Holdings' acquisition of Medical Knowledge Group from Court Square Capital and Aisling Capital, PE Hub has learned.
The purchase of the analytics-driven drug commercialization platform from Court Square Capital and Aisling Capital was announced by Novo...
Prior to Aisling Capital, Purcell served as Managing Director of the Life Sciences Investment Banking Group at Chase H&Q (formerly Hambrecht &...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.1M | 20 | -46% | $25.1M |
#2 | $2M | 20 | 0% | N/A |
#3 | $3.5M | 20 | -31% | N/A |
#4 | $2M | 20 | 5% | N/A |
#5 | $2M | 20 | -13% | N/A |